Market Research Logo

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or 'the company') is a leading global provider of pharmaceuticals, vaccines and consumer healthcare products. It is primarily involved in developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. These cater to the needs of HIV, respiratory, cancer, anti-virals, metabolic, cardiovascular and urogenital, dermatology, anti-bacterials and several other rare diseases. It merchandise and sell these products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in England, the UK.

Scope

  • Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
  • An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
  • Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.


Company Snapshot
GlaxoSmithKline Plc: Company Overview
GlaxoSmithKline Plc: Overview and Key Facts
GlaxoSmithKline Plc: Overview
GlaxoSmithKline Plc: Key Facts
GlaxoSmithKline Plc: Key Employees
GlaxoSmithKline Plc: Key Employee Biographies
GlaxoSmithKline Plc: Major Products and Services
GlaxoSmithKline Plc: Company History
GlaxoSmithKline Plc: Management Statement
GlaxoSmithKline Plc: Locations and Subsidiaries
GlaxoSmithKline Plc: Key Competitors
GlaxoSmithKline Plc: Company Analysis
GlaxoSmithKline Plc: Business Description
GlaxoSmithKline Plc: SWOT Analysis
GlaxoSmithKline Plc: SWOT Overview
GlaxoSmithKline Plc: Strengths
GlaxoSmithKline Plc: Weaknesses
GlaxoSmithKline Plc: Opportunities
GlaxoSmithKline Plc: Threats
GlaxoSmithKline Plc: Corporate Financial Deals Activity
GlaxoSmithKline Plc: Financial Deals Overview
GlaxoSmithKline Plc: Targets and Partners
GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*
GlaxoSmithKline Plc: Advisors
GlaxoSmithKline Plc: Top Legal Advisors
GlaxoSmithKline Plc: Top Financial Advisors
GlaxoSmithKline Plc: Mergers and Acquisitions
GlaxoSmithKline Plc: Corporate Venturing
GlaxoSmithKline Plc: Capital Raising
GlaxoSmithKline Plc: Partnership
GlaxoSmithKline Plc: Divestments
GlaxoSmithKline Plc: Recent Developments
GlaxoSmithKline Plc: News and Events Summary
GlaxoSmithKline Plc: Business Expansion
GlaxoSmithKline Plc: Business Reorganization
GlaxoSmithKline Plc: Contracts
GlaxoSmithKline Plc: Financial Deals
GlaxoSmithKline Plc: Financial Performance
GlaxoSmithKline Plc: Market Developments
GlaxoSmithKline Plc: Red Flags/DistressSignals
GlaxoSmithKline Plc: Regulatory and Legal Events
GlaxoSmithKline Plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 3: GlaxoSmithKline Plc: Locations and Subsidiaries
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 9: GlaxoSmithKline Plc: Targets and Partners
Table 10: GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*
Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)
Table 23: GlaxoSmithKline Plc: News and Events Summary
Table 24: GlaxoSmithKline Plc: Business Expansion
Table 25: GlaxoSmithKline Plc: Business Reorganization
Table 26: GlaxoSmithKline Plc: Contracts
Table 27: GlaxoSmithKline Plc: Financial Deals
Table 28: GlaxoSmithKline Plc: Financial Performance
Table 29: GlaxoSmithKline Plc: Market Developments
Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 32: GlaxoSmithKline Plc: Strategy and Operations
List of Figures
Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report